Baccard-Longère M, Alpha-Bazin B, Chypre C, Sauvaigo S, Téoule R, Bernard P, Seigneurin J M
Service de Virologie, C.H.U. de Grenoble, France.
J Virol Methods. 1994 Jan;46(1):29-38. doi: 10.1016/0166-0934(94)90014-0.
In some anogenital lesions the detection of certain types of human papilloma virus, especially oncogenic types, is of interest. In a first step during a prospective study, we compared two methods for the detection of human papillomavirus (HPV) DNA in clinical samples: Southern blotting followed by hybridization with a cloned radioactive genomic probe and a classical polymerase chain reaction (PCR) followed by hybridization with a 32P-labelled oligonucleotide probe. 118 biopsies and swabs were examined for HPV 6/11, 16, 18 and 33, 67 positive reactions were found by both methods, 5 positives only by PCR and 2 positives only by Southern blot for unidentified HPV. Patients with anogenital condylomas, dysplasias and carcinomas or asymptomatic patients were studied. Most high grade (II and III) dysplasias were associated with HPV 16 and HPV 18. Condylomata lesions and low grade dysplasia (grade I) were associated mostly with HPV 6/11, mixed type of HPV, less frequently with HPV 16 or HPV 18. As a second step a nested PCR coupled to solid support detection method was used as described by Sauvaigo et al. (1990) Nucleic Acids Res. 18, 3175-3183) to study a panel of 30 previously qualified different HPV DNA extracts. In this procedure the second round of PCR amplification involves biotinylated and dinitrophenylated labelled primers allowing the capture of PCR amplified HPV DNA sequences on streptavidin coated tubes and its revelation. We describe an improvement of HPV DNA detection by means of single-step immunoenzymatic revelation involving anti-DNP monoclonal antibodies conjugated to horseradish peroxidase enzyme. A perfect correlation with the previous results was obtained. This solid support method allows a faster and easier HPV typing compared to methods using membrane transfer.
在某些肛门生殖器病变中,检测某些类型的人乳头瘤病毒,尤其是致癌类型,具有重要意义。在一项前瞻性研究的第一步中,我们比较了两种在临床样本中检测人乳头瘤病毒(HPV)DNA的方法:Southern印迹法,随后与克隆的放射性基因组探针杂交;以及经典的聚合酶链反应(PCR),随后与32P标记的寡核苷酸探针杂交。对118份活检组织和拭子进行了HPV 6/11、16、18和33检测,两种方法均发现67个阳性反应,仅PCR检测出5个阳性,仅Southern印迹法检测出2个未鉴定HPV的阳性。研究对象包括患有肛门生殖器尖锐湿疣、发育异常和癌症的患者或无症状患者。大多数高级别(II级和III级)发育异常与HPV 16和HPV 18相关。尖锐湿疣病变和低级别发育异常(I级)主要与HPV 6/11、HPV混合型相关,较少与HPV 16或HPV 18相关。第二步,采用Sauvaigo等人(1990年,《核酸研究》18卷,3175 - 3183页)描述的嵌套PCR与固相支持检测方法,研究一组30份先前鉴定过的不同HPV DNA提取物。在此过程中,第二轮PCR扩增涉及生物素化和二硝基苯基化标记引物,可使PCR扩增的HPV DNA序列捕获在链霉亲和素包被的试管上并进行显色。我们描述了一种通过单步免疫酶显色改进HPV DNA检测的方法,该方法涉及与辣根过氧化物酶结合的抗DNP单克隆抗体。获得了与先前结果的完美相关性。与使用膜转移的方法相比,这种固相支持方法能更快、更轻松地进行HPV分型。